86-4597-45 Recombinant Human Angiotensin-converting enzyme 2(ACE2),partial (Active) 20ug CSB-MP866317HU
[WUHAN HUAMEI BIOTECH Co.,Ltd(CUSABIO)]仕様
- Uniprot ID:Q9BYF1
- Research Topic:Cell Biology
- Gene Names:ACE2
- Organism:Homo sapiens (Human)
- Source:Mammalian cell
- Expression Region:18-740aa
- Sequence Info:Partial
- Tag Info:C-terminal hFc-tagged
- AA Sequence:QSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNEIMANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYGDYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMNAYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQAWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDFRILMCTKVTMDDFLTAHHEMGHIQYDMAYAAQPFLLRNGANEGFHEAVGEIMSLSAATPKHLKSIGLLSPDFQEDNETEINFLLKQALTIVGTLPFTYMLEKWRWMVFKGEIPKDQWMKKWWEMKREIVGVVEPVPHDETYCDPASLFHVSNDYSFIRYYTRTLYQFQFQEALCQAAKHEGPLHKCDISNSTEAGQKLFNMLRLGKSEPWTLALENVVGAKNMNVRPLLNYFEPLFTWLKDQNKNSFVGWSTDWSPYADQSIKVRISLKSALGDKAYEWNDNEMYLFRSSVAYAMRQYFLKVKNQMILFGEEDVRVANLKPRISFNFFVTAPKNVSDIIPRTEVEKAIRMSRSRINDAFRLNDNSLEFLGIQPTLGPPNQPPVS
- MW:112.5 kDa
- Alternative Name(s):ACE 2; ACE related carboxypeptidase; ACE-related carboxypeptidase; ACE2; ACE2_HUMAN; ACEH; Angiotensin converting enzyme 2; Angiotensin converting enzyme homolog; Angiotensin converting enzyme like protein; Angiotensin I Converting Enzyme (peptidyl dipeptidase A) 2; Angiotensin I converting enzyme 2; Angiotensin-converting enzyme homolog; DKFZP434A014; EC 3.4.17; metalloprotease MPROT 15; Metalloprotease MPROT15; OTTHUMP00000022963; Processed angiotensin-converting enzyme 2
- Purity:Greater than 85% as determined by SDS-PAGE.
- Biological_Activity:①Measured by ACE2 protein (CSB-MP866317HU) binding ability in a functional ELISA.Coat the plate with 0.2μg/well (2μg/ml, 100μl/well) of SARS-CoV-2 S1 protein (CSB-MP3324GMY), add 100μl/well (0.7629-100000ng/ml, gradient dilution, 2x to 18x) of ACE2 protein and 100μl/well of Peroxidase-Affinipure Goat Anti-Human IgG, Fcγ Fragment Specific (CSB-PA160506). Wells were washed with buffer, and then A450 nm was measured. The results showed SARS-CoV-2 S1 protein could bind ACE2 protein. The EC50 is 56.64 - 103.6 ng/ml.②Measured by ACE2 protein (CSB-MP866317HU) binding ability in a functional ELISA.Coat the plate with 0.5μg/well (5μg/ml, 100μl/well) of SARS-CoV-2 S1-RBD protein (CSB-YP3324GMY1), add 100μl/well (0.762939-100000ng/ml, gradient dilution, 2x to 18x) of ACE2 protein and 100μl/well of Peroxidase-Affinipure Goat Anti-Human IgG, Fcγ Fragment Specific (CSB-PA160506). Wells were washed with buffer, and then A450 nm was measured. The results showed SARS-CoV-2 S1-RBD protein could bind ACE2 protein. The EC50 is 31.80 - 44.69 ng/ml.③Measured by ACE2 protein (CSB-MP866317HU) binding ability in a functional ELISA.Coat the plate with 0.5μg/well (5μg/ml, 100μl/well) of SARS-CoV-2 S1-RBD protein (CSB-MP3324GMY1b1), add 100μl/well (0.762939-100000ng/ml, gradient dilution, 2x to 18x) of ACE2 protein and 100μl/well of Peroxidase-Affinipure Goat Anti-Human IgG, Fcγ Fragment Specific (CSB-PA160506). Wells were washed with buffer, and then A450 nm was measured. The results showed SARS-CoV-2 S1-RBD protein could bind ACE2 protein. The EC50 is 2.785-9.139 ng/ml.④Measured by ACE2 protein (CSB-MP866317HU) binding ability in a functional ELISA.Coat the plate with 0.2μg/well (2μg/ml, 100μl/well) of ACE2 protein, add 100μl/well (0.00001164153-200000ng/ml, gradient dilution, 4x to 18x) of SARS-CoV-2 S1-RBD protein (CSB-MP3324GMY1) and 100μl/well of Peroxidase-Affinipure Goat Anti-Human IgG, Fcγ Fragment Specific (CSB-PA160506). Wells were washed with buffer, and then A450 nm was measured. The results showed SARS-CoV-2 S1-RBD protein could bind ACE2 protein. The EC50 is 8.363-12.82 ng/ml ng/ml.⑤The SPR sensorgram shows the binding between ACE2 protein (CSB-MP866317HU) and SARS-CoV-2 S1-RBD protein (CSB-YP3324GMY1).ACE2 protein was injected at 5 concentrations (400, 200, 100, 50, 0 nM) across 0.5 mg/ml of SARS-CoV-2 S1-RBD protein captured on a COOH chip. The results showed ACE2 protein could bind SARS-CoV-2 S1-RBD protein with an affinity constant of 100 nM.⑥The SPR sensorgram shows the binding between ACE2 protein (CSB-MP866317HU) and SARS-CoV-2 S1-RBD protein (CSB-MP3324GMY1b1).ACE2 protein was injected at 5 concentrations (100, 50, 25, 12.5, 0 nM) across 0.5 mg/ml of SARS-CoV-2 S1-RBD protein captured on a COOH chip. The results showed ACE2 protein could bind SARS-CoV-2 S1-RBD protein with an affinity constant of 13.8 nM.
- Activity Image Link:https://www.cusabio.com/uploadfile/protein/1/CSB-MP866317HU-AC.jpghttps://www.cusabio.com/uploadfile/protein/1/CSB-MP866317HU-AC2.jpghttps://www.cusabio.com/uploadfile/protein/1/CSB-MP866317HU-AC3.jpghttps://www.cusabio.com/uploadfile/protein/1/CSB-MP866317HU-AC4.jpghttps://www.cusabio.com/uploadfile/protein/1/CSB-MP866317HU-AC5.jpghttps://www.cusabio.com/uploadfile/protein/1/CSB-MP866317HU-AC6.jpg
- Storage Buffer:Lyophilized from Tris/PBS-based buffer, 6% Trehalose, pH 8.0
- Image Description:(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
- Endotoxin:Less than 1.0 EU/ug as determined by LAL method.
- Form:Lyophilized powder
- Reconstitution:We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
- サイズ:20ug
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]
商品のバリエーション (サイズ違い・スペック違い・オプション品など)
よくあるご質問(FAQ)
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|





